Federal Register / Vol. 72, No.
2 / Thursday, January 4, 2007 / Notices 343
burden statement notices contained on
each form. Finally, the FCC Form 486
has been modified to include a new
certification that certain steps have been
taken prior to the commencement of
service (see the Fifth Report and Order,
CC Docket No. 02–6, FCC 04–190). The
FCC Forms 479 and 500 remain
unchanged since the last submission to
the OMB.
The purpose of this information
collection is to ensure that schools and
libraries that are eligible to receive
discounted Internet access and internal
connections have in place certain
Internet safety policies. Libraries
receiving Internet access and internal
connection services supported by the
schools and libraries support
mechanism must certify, by completing
the FCC Form 486 (Receipt of Service
Confirmation Form), the respondents
are indicating they are enforcing a
policy of Internet safety and enforcing
the operation of a technology prevention
measure. Respondents who received a
Funding Commitment Decision Letter
indicating services eligible for universal
service discounts must file FCC Form
486 in order to start the payment
process. In addition, all members of a
consortium must submit signed
certifications to the Billed Entity (using
a FCC Form 479, Certification by
Administrative Authority to Billed
Entity of Compliance with Children’s
Internet Protection Act (CIPA)) of each
consortium, in language consistent with
that adopted on the FCC Form 486. FCC
Form 500 is used in conjunction with
the FCC Form 486 to adjust funding
commitments and/or modify the dates
for receipt of service.
OMB Control Number: 3060–0856.
Title: Universal Service—Schools and
Libraries Universal Service Program
Reimbursement Forms.
Form Nos.: FCC Forms 472, 473 and
474.
Type of Review: Revision of a
currently approved collection.
Respondents: Business or other for-
profit, not-for-profit institutions and
state, local or tribal government.
Number of Respondents: 21,200
respondents; 91,100 responses.
Estimated Time Per Response: 1–1.5
hours.
Frequency of Response: On occasion
and annual reporting requirements and
third party disclosure requirement.
Obligation to Respond: Required to
obtain or retain benefits.
mstockstill on PROD1PC61 with NOTICES
Total Annual Burden: 133,650 hours.
Total Annual Cost: N/A.
Privacy Act Impact Assessment: N/A.
Nature and Extent of Confidentiality:
The Commission does not request that
respondents submit confidential
VerDate Aug<31>2005 15:51 Jan 03, 2007 Jkt 211001
information to the Commission. If the
Commission requests applicants to
submit information that the respondents
believe is confidential, respondents may
request confidential treatment of such
information under section 47 CFR 0.459
of the Commission’s rules.
Needs and Uses: The Commission
will submit this information collection
to OMB as a revision during this
comment period to obtain the full three-
year clearance from them. The
Commission has revised this collection
since it was last submitted to OMB. The
forms have been revised to include new
certifications that the service provider
has complied with the competitive
bidding requirements of the program,
pursuant to the Fifth Report and Order,
(CC Docket No. 02–6, FCC 04–190). In
addition, to reduce confusion, the FCC
Form 473 will contain information
about one SPIN (rather than multiple
SPINs). Note: A SPIN is a Service
Provider Identification Number. The
burden hours on all three forms and
their instructions have been updated.
All three forms also contain updated
notices for individuals as required by
the Privacy Act and the Paperwork
Reduction Act.
The purpose of the FCC Form 472 is
to establish the process and procedure
for an eligible entity to seek
reimbursement from the service
provider for the discounts on services
paid in full. After receiving an invoice
from the service provider, together with
an FCC Form 472, the fund
administrator is able to verify the
eligible service and approved amounts
that should be reimbursed and can make
the appropriate payment. The FCC Form
472 is used to ensure that each service
provider has provided discounted
services within the current funding year
for which it submits an invoice to the
Administrator and that invoices
submitted from service providers for the
costs of discounted eligible services do
not exceed the amount that has been
approved.
The purpose of the FCC Form 473 is
to establish that the participating service
provider is eligible to participate in the
program under the FCC’s rules
governing the schools and libraries
universal service support mechanism
pursuant to the Act. The FCC 473 is
used by the Administrator to assure that
the dollars paid out by the fund to
service providers go to eligible
providers.
The purpose of the FCC Form 474 is
to establish the process and procedure
for a service provider to seek payment
for the discounted costs of services it
provided to Billed Entities for eligible
services. After receiving an invoice from
PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 E:\FR\FM\04JAN1.SGM
the service provider, together with an
FCC Form 474, the fund administrator is
able to verify that the eligible and
approved amounts can be paid. The FCC
Form 474 is used to ensure that each
service provider has provided
discounted services within the current
funding year for which it submits an
invoice to the Administrator and that
invoices submitted from service
providers for the costs of discounted
eligible services do not exceed the
amount that has been approved.
All of the requirements contained in
this information collection are necessary
to implement the congressional mandate
for universal service.
Federal Communications Commission.
William F. Caton,
Deputy Secretary.
[FR Doc. E6–22324 Filed 1–3–07; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
04JAN1
 344 Federal Register / Vol. 72, No. 2 / Thursday, January 4, 2007 / Notices
indicated or the offices of the Board of
Governors not later than January 26,
2006.
A. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) 411 Locust Street, St. Louis,
Missouri 63166-2034:
1. Enterprise Financial Services Corp.,
Clayton, Missouri; to acquire 100
percent of the voting shares of Clayco
Banc Corporation, DeSoto, Kansas, and
thereby indirectly acquire Great
American Bank, DeSoto, Kansas.
Board of Governors of the Federal Reserve
System, December 28, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E6–22532 Filed 1–3–07; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Summaries of Medical and Clinical
Pharmacology Reviews of Pediatric
Studies; Availability
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of summaries of medical
and clinical pharmacology reviews of
pediatric studies submitted in
supplements for AZOPT (brinzolamide),
BETAXON (levobetaxolol), and
GLEEVEC (imatinib). These summaries
are being made available consistent with
the Best Pharmaceuticals for Children
Act (the BPCA). For all pediatric
supplements submitted under the
BPCA, the BPCA requires FDA to make
available to the public a summary of the
medical and clinical pharmacology
reviews of the pediatric studies
conducted for the supplement.
ADDRESSES: Submit written requests for
single copies of the summaries to the
Division of Drug Information (HFD–
240), Center for Drug Evaluation and
Research, Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857. Please specify by
product name which summary or
summaries you are requesting. Send one
self-addressed adhesive label to assist
that office in processing your requests.
mstockstill on PROD1PC61 with NOTICES
See the SUPPLEMENTARY INFORMATION
section for electronic access to the
summaries.
FOR FURTHER INFORMATION CONTACT:
Grace Carmouze, Center for Drug
VerDate Aug<31>2005 15:51 Jan 03, 2007 Jkt 211001
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 6460,
Silver Spring, MD 20993–0002, 301–
796–0700, e-mail:
grace.carmouze@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
summaries of medical and clinical
pharmacology reviews of pediatric
studies conducted for AZOPT
(brinzolamide), BETAXON
(levobetaxolol), and GLEEVEC
(imatinib). The summaries are being
made available consistent with section 9
of the BPCA (Public Law 107–109).
Enacted on January 4, 2002, the BPCA
reauthorizes, with certain important
changes, the pediatric exclusivity
program described in section 505A of
the Federal Food, Drug, and Cosmetic
Act (the act) (21 U.S.C. 355a). Section
505A of the act permits certain
applications to obtain 6 months of
marketing exclusivity if, in accordance
with the requirements of the statute, the
sponsor submits requested information
relating to the use of the drug in the
pediatric population.
One of the provisions the BPCA
added to the pediatric exclusivity
program pertains to the dissemination of
pediatric information. Specifically, for
all pediatric supplements submitted
under the BPCA, the BPCA requires
FDA to make available to the public a
summary of the medical and clinical
pharmacology reviews of pediatric
studies conducted for the supplement
(21 U.S.C. 355a(m)(1)). The summaries
are to be made available not later than
180 days after the report on the
pediatric study is submitted to FDA (21
U.S.C. 355a(m)(1)). Consistent with this
provision of the BPCA, FDA has posted
on the Internet at http://www.fda.gov/
cder/pediatric/index.htm summaries of
medical and clinical pharmacology
reviews of pediatric studies submitted
in supplements for AZOPT
(brinzolamide), BETAXON
(levobetaxolol), and GLEEVEC
(imatinib). Copies are also available by
mail (see ADDRESSES).
II. Electronic Access
Persons with access to the Internet
may obtain the document at http://
www.fda.gov/cder/pediatric/index.htm.
Dated: December 22, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–22517 Filed 1–3–07; 8:45 am]
BILLING CODE 4160–01–S
PO 00000 Frm 00019 Fmt 4703 Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice.
SUMMARY: The Health Resources and
Services Administration (HRSA) is
publishing this notice of petitions
received under the National Vaccine
Injury Compensation Program (‘‘the
Program’’), as required by Section
2112(b)(2) of the Public Health Service
(PHS) Act, as amended. While the
Secretary of Health and Human Services
is named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact the Clerk, United States
Court of Federal Claims, 717 Madison
Place, NW., Washington, DC 20005,
(202) 357–6400. For information on
HRSA’s role in the Program, contact the
Director, National Vaccine Injury
Compensation Program, 5600 Fishers
Lane, Room 11C–26, Rockville, MD
20857; (301) 443–6593.
SUPPLEMENTARY INFORMATION: The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of Health and Human
Services, who is named as the
respondent in each proceeding. The
Secretary has delegated his
responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at Section
2114 of the PHS Act or as set forth at
42 CFR 100.3, as applicable. This Table
E:\FR\FM\04JAN1.SGM 04JAN1